Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
35,773,173
-
Shares change
-
+135,621
-
Total reported value, excl. options
-
$293,344,147
-
Value change
-
-$8,655,319
-
Put/Call ratio
-
62%
-
Number of buys
-
58
-
Number of sells
-
28
-
Price
-
$8.20
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2017
As of 31 Dec 2017 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,773,173 shares of stock of the company.
Largest 10 holders included FMR LLC, BRIDGER MANAGEMENT, LLC, BlackRock Inc., STATE STREET CORP, venBio Select Advisor LLC, FRANKLIN RESOURCES INC, Vanguard Group Inc, SENZAR ASSET MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and NORTHERN TRUST CORP.
This table shows 129 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.